Stroke Management Global Market Report 2025

Stroke management involves the treatment administered when a blood vessel in the brain bursts or when something obstructs the blood flow to a specific area of the brain, resulting in the brain aging or sustaining damage.

The primary product categories within stroke management include diagnostics, drug therapy products, and interventional stroke management systems. Diagnostics pertain to procedures aimed at identifying a disease, ailment, or injury based on its symptoms and indications. These diagnostic tools find applications in various scenarios such as ischemic stroke and hemorrhagic stroke. Additionally, they cater to diverse end-users, including hospitals, clinics, ambulatory surgery centers, diagnostic centers, retail pharmacies, online pharmacies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The stroke management market research report is one of a series of new reports from The Business Research Company that provides stroke management market statistics, including stroke management industry global market size, regional shares, competitors with a stroke management market share, detailed stroke management market segments, market trends and opportunities, and any further data you may need to thrive in the stroke management industry. This stroke management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stroke management market size has grown strongly in recent years. It will grow from $40.24 billion in 2024 to $43.15 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to thrombolytic therapies, stroke prevention initiatives, rehabilitation techniques, telemedicine in stroke care, collaborative stroke networks.

The stroke management market size is expected to see strong growth in the next few years. It will grow to $57.88 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to emergence of neuroprotective therapies, artificial intelligence in stroke diagnosis, personalized medicine approaches, expanding access to acute care, global stroke care standardization. Major trends in the forecast period include advancements in medical imaging technology, telemedicine and remote monitoring, focus on preventive care and risk factor management, neuroprotective therapies and drug innovations, collaboration and multidisciplinary approaches.

The forecast of 7.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. post-stroke rehabilitation by inflating prices of robotic exoskeletons and neuroplasticity training software developed in France and Singapore, resulting in prolonged recovery periods and higher neurorehabilitation costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of chronic diseases is expected to drive the growth of the stroke management market in the future. Chronic diseases are defined as conditions that persist for a year or longer and hinder daily activities, often requiring ongoing medical care. Stroke management plays a crucial role in supporting patients with various chronic conditions, such as cancer and cardiovascular diseases, by focusing on preventive care, education, and empowering patients, as well as developing integrated care delivery models that combine primary and secondary care. For instance, in August 2022, a report from the American College of Cardiology, a U.S.-based non-profit medical association, projected that all four major cardiovascular risk factors in the United States will increase from 2025 to 2060. Diabetes is expected to see the most significant rise, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Additionally, substantial increases in cardiovascular disease rates are anticipated, including stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), with ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million) following closely. Therefore, the increasing incidence of chronic diseases is driving the growth of the stroke management market.

The increasing geriatric population is expected to drive the growth of the stroke management market in the future. The geriatric population includes individuals aged 65 and older, a demographic characterized by various biological, sociological, and psychological changes associated with aging. For example, in January 2024, the Population Reference Bureau, a U.S.-based nonprofit organization focused on collecting and providing statistics, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Therefore, the growing geriatric population is a significant factor propelling the growth of the stroke management market.

Major companies in the stroke management market are increasingly focused on developing neurovascular technology to improve the diagnosis, treatment, and recovery processes for stroke patients. Neurovascular technology includes medical devices, techniques, and procedures aimed at diagnosing, treating, and managing conditions related to the brain's blood vessels and the nervous system. For example, in October 2022, Medtronic, an Ireland-based company specializing in medical technologies, launched a new platform designed to accelerate innovation in stroke care. This platform combines advanced imaging and data analytics to enhance decision-making, streamline workflows, and improve patient outcomes during stroke interventions. The new technology aims to equip clinicians with better tools for rapid diagnosis and treatment, facilitating timely interventions that can significantly mitigate the effects of strokes on patients.

Major players in the stroke management market are directing their efforts towards introducing innovative products, such as a portfolio of Ischemic stroke solutions, to gain a competitive advantage. An example is MicroVention Inc., a US-based neuroendovascular medical device company, which launched the Eric retrieval device for treating ischemic stroke in the US in June 2023. Eric, a self-expanding laser-cut clot retriever, features multiple retrieval cages on a pusher wire delivery system. MicroVention emphasizes the device's atraumatic design, following natural vessel guidelines to provide mild outward radial force, minimal vessel wall contact, and remarkable flexibility.

In December 2022, Johnson & Johnson, a US-based pharmaceutical industry company, acquired Abiomed, Inc. This strategic move aimed to expand Johnson & Johnson's MedTech business growth, delivering cutting-edge medical innovations globally. Abiomed Inc., a US-based medical device technology company, specializes in developing and manufacturing stroke management devices, including heart pumps.

Major companies operating in the stroke management market include GE HealthCare Technologies Inc., Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B Braun Melsungen AG, Bristol Myers Squibb Co., Cardinal Health Inc., Siemens Healthineers, Merck And Co. Inc., Asahi Intech Co. Ltd., Johnson & Johnson, Penumbra Inc., Teleflex Inc., Stryker Corporation, Biogen Inc., Bayer AG, Philips Healthcare, AstraZeneca Plc., F. Hoffmann-la Roche, Novartis AG, Takeda Pharmaceutical Company Ltd., Sanofi SA, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Pfizer Inc.

North America was the largest region in the stroke management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global stroke management market report during the forecast period. The regions covered in the stroke management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the stroke management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The stroke management market includes revenues earned by entities by providing hyperacute care, acute care, rehabilitation, control of bleeding, and basic life support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stroke Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stroke management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stroke management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stroke management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Diagnostics; Drug Therapy Products; Interventional Stroke Management Systems
• 2) By Application: Ischemic Stroke; Hemorrhagic Stroke
• 3) By End-User: Hospitals; Clinics; Ambulatory Surgery Centers; Diagnostic Centers; Retail Pharmacies; Online Pharmacies; Other End Users
• Subsegments:
• 1) By Diagnostics: Imaging Systems; Diagnostic Software; Blood Tests
• 2) By Drug Therapy Products: Anticoagulants; Antiplatelet Drugs; Thrombolytic Agents; Antihypertensive Drugs
• 3) By Interventional Stroke Management Systems: Clot Retrieval Devices; Stent Retrievers; Embolic Protection Devices; Carotid Artery Stenting Systems
• Companies Mentioned: GE HealthCare Technologies Inc.; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; B Braun Melsungen AG; Bristol Myers Squibb Co.; Cardinal Health Inc.; Siemens Healthineers; Merck And Co. Inc.; Asahi Intech Co. Ltd.; Johnson & Johnson; Penumbra Inc.; Teleflex Inc.; Stryker Corporation; Biogen Inc.; Bayer AG; Philips Healthcare; AstraZeneca Plc.; F. Hoffmann-la Roche; Novartis AG; Takeda Pharmaceutical Company Ltd.; Sanofi SA; Daiichi Sankyo Company Limited; Boehringer Ingelheim International GmbH; Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.